- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01113606
A Trial of Skin Care Protocols for Facial Resurfacing (SPAR)
April 29, 2010 updated by: The Plastic Surgery Foundation
A Double-Blind, Randomized, Controlled Trial to Assess the Effects of the Obagi Nu-Derm System on Re-Epithelialization After Chemical Peel or Ablative Laser Resurfacing.
The aims of the Skin Product Assessment Research study were to (1) develop an infrastructure and process for industry-sponsored, Plastic Surgery Educational Foundation (PSEF) research in facial aesthetic surgery and (2) test the research process by comparing outcomes of the Obagi Nu-Derm System (ODNS) and conventional therapy as treatment adjuncts in ablative facial resurfacing.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Oxnard, California, United States, 93030
- Suite 135
-
Rancho Santa Margarita, California, United States, 92688
- Suite 175
-
-
Colorado
-
Greeley, Colorado, United States, 80634
- Aesthetic and Plastic Surgery Institute
-
-
Florida
-
Melbourne, Florida, United States, 32901
- Brevard Plastic Surgery and Skin Institute
-
-
Kentucky
-
Louisville, Kentucky, United States, 40202
- Kentucky Aesthetic and Plastic Surgery Institute
-
-
Michigan
-
Ypsilanti, Michigan, United States, 48197
- Center for Plastic and Reconstructive Surgery
-
-
Missouri
-
St. Louis, Missouri, United States, 63141
- Body Aesthetic Plastic Surgery
-
-
New York
-
New York, New York, United States
-
-
South Carolina
-
Greenville, South Carolina, United States, 29607
- Advanced Cosmetis Surgery
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- patients with moderate to severe photo damage and rhytids, undergoing full or partial face resurfacing with chemical peel or ablative laser.
- Fitzpatrick I-IV skin types
Exclusion Criteria:
- patients unable to complete the regimen or who had used topical prescription steroids, retinoids, depigmentation products or other products containing hydroquinone and polyhydroxy acids within 8 weeks of enrollment.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Standard of Care
|
|
Active Comparator: Obagi Nu-Derm System (ONDS)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Registration Dates
First Submitted
April 28, 2010
First Submitted That Met QC Criteria
April 29, 2010
First Posted (Estimate)
April 30, 2010
Study Record Updates
Last Update Posted (Estimate)
April 30, 2010
Last Update Submitted That Met QC Criteria
April 29, 2010
Last Verified
April 1, 2010
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PSEF001-06
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Facial Photo Damage
-
PeplinCompleted
-
Seoul National University HospitalCompletedAgeing | Photo-agingKorea, Republic of
-
DeYi Aesthetic Medical ClinicNot yet recruiting
-
DeYi Aesthetic Medical ClinicNot yet recruiting
-
Seoul National University HospitalCompleted
-
Derming SRLCompletedFace Aging/Photo Aging of Moderate GradeItaly
-
West Penn Allegheny Health SystemCompletedHemodialysis | Hypotension | Circulatory Stress | Photo-plethysmographyUnited States
-
University of MichiganBausch Health Americas, Inc.Completed
-
Skin Laser & Surgery SpecialistsLEO PharmaCompletedClinical and Histologic Evaluation of Picato 0.15% Gel in the Cosmetic Improvement of Photoaged SkinActinic Keratosis | Photo-aged Skin
-
Chinese University of Hong KongUnknownPhoto Neuro-Modulation Therapy, Mild Cognitive ImpairmentHong Kong
Clinical Trials on Standard of Care
-
brett rasmussenCompleted
-
Johns Hopkins UniversityRecruitingCompartment Syndrome of Leg | Extracorporeal Membrane Oxygenation Complication | Limb Ischemia, Critical | Limb IschemiaUnited States
-
Indonesia UniversityCompletedCovid19 | AcupunctureIndonesia
-
Aventusoft, LLC.National Heart, Lung, and Blood Institute (NHLBI); Cleveland Clinic FloridaRecruitingHeart Failure (HF)United States
-
Vascular Biogenics Ltd. operating as VBL TherapeuticsCompletedSevere COVID-19Israel
-
Ruijin HospitalRecruitingCOVID-19 PneumoniaChina
-
Institut Claudius RegaudCompletedMETASTATIC CANCERFrance
-
Ziv HospitalNot yet recruiting
-
Hofseth Biocare ASAKGK Science Inc.CompletedCovid-19 | COVIDCanada, Brazil, Hungary, Mexico, Serbia
-
City University of New York, School of Public HealthNew York State Psychiatric Institute; University of KwaZulu; International Initiative... and other collaboratorsCompleted